Resverlogix Announces New Insights into the Mechanism of Apabetalone’s Cardioprotective Benefit in Chronic Kidney Disease Patients
Calgary, Alberta–(Newsfile Corp. – June 12, 2023) – Resverlogix Corp. (TSX: RVX) (“Resverlogix”) today announced…
Calgary, Alberta–(Newsfile Corp. – June 12, 2023) – Resverlogix Corp. (TSX: RVX) (“Resverlogix”) today announced…
Odessa, TX – Reyna Law Firm (432-232-5183) has announced upgrades to its personal injury law…
Toronto, Ontario–(Newsfile Corp. – June 12, 2023) – American Aires Inc. (CSE: WIFI) (OTC: AAIRF)…
The markets may be down, but online threats are up. WASHINGTON–(BUSINESS WIRE)–Pyrra Technologies Inc. (“Pyrra”…
l CMS is pleased to announce the NDA of the first Diazepam Nasal Spray has…
KUALA LUMPUR, Jun 12, 2023 – (ACN Newswire) – Despite professed commitments to create a…
FLORENCE, ITALY & WEST PALM BEACH, FL, Jun 12, 2023 – (ACN Newswire) – U….
BigBear.ai will continue work as single-source prime contractor in transforming 15 legacy U.S. Army systems…
AI Cloud is built for CRM – supercharging customer experiences and company productivity by bringing…
New data from PERIO-01 clinical trial indicates PEDD™ method resulted in modulation of the tumor…
Our Board is Refreshed, Diverse and Well-Qualified – We Cannot Afford to Lose the Vital…
HONG KONG, Jun 12, 2023 – (ACN Newswire) – DOTTED, the mobile-first Web3 platform founded…
SINGAPORE, Jun 12, 2023 – (ACN Newswire) – On June 6, the Asia Video Industry…
Despite increased scrutiny of technology investments, new era of innovation calls for a digital-first mindset…
MILAN & WASHINGTON–(BUSINESS WIRE)–Following the formation of the European DTx Policy Coalition by Healthware Group…
KIRKLAND, Wash.–(BUSINESS WIRE)–Appen Limited (ASX:APX), a global leader in providing data services for deep learning…
Enables access to additional Latin America data to support equitable healthcare in cardiovascular R&D ZURICH,…
According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to…
According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to…
Bagsværd, Denmark, 12 June 2023 – Novo Nordisk today announced plans to invest 15.9 billion…